1) $VTVT Phase 2 positive results for insulin diabetes (2.10)
Stock Gapping up +1.80 do NOT BUY this unless you get a quick push at open to $4.20 with serious buyer(s) then look for solid push to $5 spot or more top it off then slow gap-fill fade back down to $3 spot and under if small push at the open then lower lows set in look to fade this all day long back down to $3 and under
2) $ADVM positive results for the Phase 1 trial (10.24)
Stock Gapping up +2.20 do NOT buy this crap unless you get a push at open towards $13 area then quick push to $14 then top it off for all day fader back to $10.50-$10.75 and under, if this small pops at the open and lower lows set in, expect and all day fader to $10.50 and under
3) $MYOV expects to report results on relugolix in 1Q20 (13.01) Stupid!!!
Stock Gapping up +2.50 this is nothing more than a pop and drop any pop at the open AGAIN at $15+ scale in short and look to fade this all day long, nothing here.
4) $STOK Gapping up on NO NEWS (28.04)
Stock Gapping up THIN +4.00 anything at $31-$32 is nothing more than pop and fade all the way back to $28.50 and under, more it pops at the open better the range for us to the downside
5) $EPC Earnings Beat BUT LOWERS F20 Guidance (30.48)
Stock Gapping up +7.50 would try and take small nibble short at $37 area room to $39 pop at the open once this breaks $36 this should fade back down to $32 and under. Not sure why this is up so much so watch the break at the open, once it snaps we get the fade was looking for.
6) $WWE Wells Fargo Tier 3 firm out with a $36PT from $80 OUCH (42.53)
Stock Gapping down -1.40 like to see pull at the open towards $38.50-$39 area then quick short cover bounce back to $41.50+ top it off then all day fader on it if this pops at all at the open (wish it would do that first) and gap fills to $42+ scale in short for an all-day fader on it
7) $CRMT To join the S&P 600 on 2/13 (106.78)
Stock Gapping up +8.00 like to see small pop at the open towards $116-$118 area watch for topping once this snaps $115 we should get a nice fade to $108-$110 area and be done with it, the more it pops today better the range for us to the downside due to the market being down
8) $AAPL coronavirus impact on semiconductor issues with the plant (320.03)
Stock Gapping down -$6 do NOT BUY this unless you get the pop at the open towards $316 then chase a few to $318+ gap-fill short cover, top it off then look to fade it again throughout the day. If this snaps hard at open watch the $312-$313 area for shorts to come in and cover 3-4pts
9) $BIIB Eli Lilly Roche slide after Alzheimer’s drug fails (338.70) There NOT $BIIB
Stock Gapping down -$9 would love to see this head back to $334-$336 at the open then look for topping on it then we can get a nice fade to $328-$330 area if this snaps at open hard to same area bottom curl it then slow all day move to the upside on short covers slow
10) $TSLA +Forbes piece indicating $GOOG may want to buy co for $1500 a share (748.07)
Stock Gapping up +$44 do NOT BUY this unless we see at $820 pop at open then quick rush to $850 then look for a decent -$60-$80 point pullback would love to see $760-$770 pull on it then bottom curl then a solid move 75+ points or more to the upside. If your new to trading this is not for you. For me, once this pushes I will be playing this with 100-200 shares in and out so quick should be a wild ride
$MRNA February calls active plus over the weekend News there working on a vaccine (23.24) Gapping up +1.90 nothing more then a full gap fill back to $23-$23.50 and under then bottom curl it for slow all day move to the upside
$GNRC NO MM’s on it yet up thin joining the S&P 400 (101.35) Gapping up +5.50 would love to see a little more pop at the open towards $108-$110 area than top it off then look to fade this back down to $103.50-$105 area then be done with it
$BYND Gapping up on NO NEWS (116.44) Gapping up +3.50 would love to see this gap-fill to $117 and under then quick pop again to $120-$122 top it off then slow fade back down to gap-fill or lower should be fun
Copyright © 2020 by Awesomecalls Inc.
No part of this content may be reproduced, distributed, or transmitted in any form or by any means without the prior written permission of the publisher. Full legal action will be taken. ALL RIGHTS RESERVED